BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20971952)

  • 1. Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.
    Chen R; Guo L; Chen Y; Jiang Y; Wierda WG; Plunkett W
    Blood; 2011 Jan; 117(1):156-64. PubMed ID: 20971952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.
    Chen R; Wierda WG; Chubb S; Hawtin RE; Fox JA; Keating MJ; Gandhi V; Plunkett W
    Blood; 2009 May; 113(19):4637-45. PubMed ID: 19234140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells.
    Tang R; Faussat AM; Majdak P; Marzac C; Dubrulle S; Marjanovic Z; Legrand O; Marie JP
    Mol Cancer Ther; 2006 Mar; 5(3):723-31. PubMed ID: 16546987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.
    Balakrishnan K; Burger JA; Wierda WG; Gandhi V
    Blood; 2009 Jan; 113(1):149-53. PubMed ID: 18836097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
    Tromp JM; Geest CR; Breij EC; Elias JA; van Laar J; Luijks DM; Kater AP; Beaumont T; van Oers MH; Eldering E
    Clin Cancer Res; 2012 Jan; 18(2):487-98. PubMed ID: 22128299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.
    Balakrishnan K; Burger JA; Quiroga MP; Henneberg M; Ayres ML; Wierda WG; Gandhi V
    Blood; 2010 Aug; 116(7):1083-91. PubMed ID: 20442367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia.
    Chen R; Zhu M; Chaudhari RR; Robles O; Chen Y; Skillern W; Qin Q; Wierda WG; Zhang S; Hull KG; Romo D; Plunkett W
    Leukemia; 2019 Jul; 33(7):1663-1674. PubMed ID: 30700841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin.
    Kuroda J; Kamitsuji Y; Kimura S; Ashihara E; Kawata E; Nakagawa Y; Takeuichi M; Murotani Y; Yokota A; Tanaka R; Andreeff M; Taniwaki M; Maekawa T
    Int J Hematol; 2008 Jun; 87(5):507-515. PubMed ID: 18415656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
    Visani G; Russo D; Ottaviani E; Tosi P; Damiani D; Michelutti A; Manfroi S; Baccarani M; Tura S
    Leukemia; 1997 May; 11(5):624-8. PubMed ID: 9180282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.
    Balakrishnan K; Burger JA; Fu M; Doifode T; Wierda WG; Gandhi V
    Neoplasia; 2014 Dec; 16(12):1036-46. PubMed ID: 25499217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms.
    Nguyen T; Parker R; Zhang Y; Hawkins E; Kmieciak M; Craun W; Grant S
    BMC Cancer; 2018 Nov; 18(1):1129. PubMed ID: 30445933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia.
    Yi X; Sarkar A; Kismali G; Aslan B; Ayres M; Iles LR; Keating MJ; Wierda WG; Long JP; Bertilaccio MTS; Gandhi V
    Clin Cancer Res; 2020 Jul; 26(14):3856-3867. PubMed ID: 31937611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.
    Chen LS; Redkar S; Bearss D; Wierda WG; Gandhi V
    Blood; 2009 Nov; 114(19):4150-7. PubMed ID: 19734450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.
    McCaig AM; Cosimo E; Leach MT; Michie AM
    Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP).
    Yinjun L; Jie J; Weilai X; Xiangming T
    Am J Hematol; 2004 Jul; 76(3):199-204. PubMed ID: 15224352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells.
    Yin S; Wang R; Zhou F; Zhang H; Jing Y
    Mol Pharmacol; 2011 Jun; 79(6):1072-83. PubMed ID: 21415308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
    Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
    Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death.
    Chen R; Keating MJ; Gandhi V; Plunkett W
    Blood; 2005 Oct; 106(7):2513-9. PubMed ID: 15972445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor.
    Lindqvist LM; Vikström I; Chambers JM; McArthur K; Ann Anderson M; Henley KJ; Happo L; Cluse L; Johnstone RW; Roberts AW; Kile BT; Croker BA; Burns CJ; Rizzacasa MA; Strasser A; Huang DC
    Cell Death Dis; 2012 Oct; 3(10):e409. PubMed ID: 23059828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
    Ghosh AK; Kay NE; Secreto CR; Shanafelt TD
    Clin Cancer Res; 2009 Feb; 15(4):1250-8. PubMed ID: 19228728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.